MA20019A1 - Procede pour l'obtention de derives de la pyridazine ayant une action psychotrope. - Google Patents

Procede pour l'obtention de derives de la pyridazine ayant une action psychotrope.

Info

Publication number
MA20019A1
MA20019A1 MA20240A MA20240A MA20019A1 MA 20019 A1 MA20019 A1 MA 20019A1 MA 20240 A MA20240 A MA 20240A MA 20240 A MA20240 A MA 20240A MA 20019 A1 MA20019 A1 MA 20019A1
Authority
MA
Morocco
Prior art keywords
obtaining
pyridazine derivatives
psychotropic action
psychotropic
action
Prior art date
Application number
MA20240A
Other languages
English (en)
French (fr)
Inventor
Kan Jean-Paul
Biziere Kathleen
Wermuth Camille-Georges
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8301366A external-priority patent/FR2540115B1/fr
Priority claimed from FR8318433A external-priority patent/FR2555178B1/fr
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of MA20019A1 publication Critical patent/MA20019A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MA20240A 1983-01-28 1984-01-26 Procede pour l'obtention de derives de la pyridazine ayant une action psychotrope. MA20019A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8301366A FR2540115B1 (fr) 1983-01-28 1983-01-28 Derive de la pyridazine ayant une action psychotrope, son mode de preparation et les medicaments en contenant
FR8318433A FR2555178B1 (fr) 1983-11-18 1983-11-18 Derives cyanes de la pyridazine ayant une action psychotrope, leur mode de preparation et les medicaments en contenant

Publications (1)

Publication Number Publication Date
MA20019A1 true MA20019A1 (fr) 1984-10-01

Family

ID=26223263

Family Applications (1)

Application Number Title Priority Date Filing Date
MA20240A MA20019A1 (fr) 1983-01-28 1984-01-26 Procede pour l'obtention de derives de la pyridazine ayant une action psychotrope.

Country Status (25)

Country Link
US (2) US4565814A (en:Method)
EP (1) EP0116494B1 (en:Method)
KR (1) KR910000639B1 (en:Method)
AU (1) AU566352B2 (en:Method)
CA (1) CA1218655A (en:Method)
CS (1) CS274405B2 (en:Method)
DD (1) DD215542A5 (en:Method)
DE (1) DE3469026D1 (en:Method)
DK (3) DK159969C (en:Method)
ES (1) ES529108A0 (en:Method)
FI (1) FI77453C (en:Method)
GR (1) GR81682B (en:Method)
HU (1) HU192975B (en:Method)
IE (1) IE56750B1 (en:Method)
IL (1) IL70755A (en:Method)
MA (1) MA20019A1 (en:Method)
NO (1) NO840329L (en:Method)
NZ (1) NZ206957A (en:Method)
OA (1) OA07645A (en:Method)
PH (1) PH21476A (en:Method)
PL (1) PL143994B1 (en:Method)
PT (1) PT77994B (en:Method)
SG (1) SG9389G (en:Method)
SU (1) SU1274623A3 (en:Method)
YU (1) YU14184A (en:Method)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2540113A1 (fr) * 1983-01-27 1984-08-03 Sanofi Sa Acides derives de la pyridazine actifs sur le systeme nerveux central
PT82753B (pt) * 1985-06-14 1988-12-15 Lilly Co Eli Processo para a preparacao de piridazinas uteis como fungicidas
US5106973A (en) * 1987-11-23 1992-04-21 Janssen Pharmaceutica N.V. Pyridzainamine derivatives
DK1112743T3 (da) * 1998-08-20 2007-11-26 Toyama Chemical Co Ltd Nitrogenholdige heterocykliske carboxamidderivater eller salte deraf som antivirale midler
ES2339738T3 (es) 1999-01-22 2010-05-25 Elan Pharmaceuticals, Inc. Derivados de acilo los cuales tratan trastornos relacionados con vla-4.
TW200307671A (en) 2002-05-24 2003-12-16 Elan Pharm Inc Heteroaryl compounds which inhibit leukocyte adhesion mediated by α 4 integrins
TWI281470B (en) 2002-05-24 2007-05-21 Elan Pharm Inc Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins
AU2005260102A1 (en) * 2004-05-08 2006-01-12 Novartis International Pharmaceutical Ltd. 3-aryl-5,6-disubstituted pyridazines
EP1741709A1 (en) * 2005-06-28 2007-01-10 Sanofi-Aventis Deutschland GmbH Heteroaryl-substituted amides comprising a saturated linker group, and their use as pharmaceuticals
AU2006297180A1 (en) 2005-09-29 2007-04-12 Elan Pharmaceuticals, Inc. Carbamate compounds which inhibit leukocyte adhesion mediated by VLA-4
EP1940826B1 (en) 2005-09-29 2010-12-29 Elan Pharmaceuticals Inc. Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
EA017110B1 (ru) 2006-02-27 2012-09-28 Элан Фамэсьютикэлс, Инк. ПИРИМИДИНИЛСУЛЬФОНАМИДНЫЕ СОЕДИНЕНИЯ (ВАРИАНТЫ), СПОСОБ ПОЛУЧЕНИЯ ПИРИМИДИНИЛСУЛЬФОНАМИДНЫХ СОЕДИНЕНИЙ (ВАРИАНТЫ), ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ЗАБОЛЕВАНИЯ, ОПОСРЕДОВАННОГО ИНТЕГРИНОМ α4, СПОСОБ СНИЖЕНИЯ И/ИЛИ ПРЕДУПРЕЖДЕНИЯ ВОСПАЛИТЕЛЬНОГО КОМПОНЕНТА ЗАБОЛЕВАНИЯ ИЛИ АУТОИММУННОГО ОТВЕТА
SG10201401836RA (en) 2009-04-27 2014-10-30 Elan Pharm Inc Pyridinone antagonists of alpha-4 integrins
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345880A (en) * 1971-06-18 1974-02-06 Cepbepe Pyridazine derivatives
FR2510998B1 (fr) * 1981-08-07 1986-01-10 Sanofi Sa Nouveaux derives amines de la pyridazine, leur procede de preparation et les medicaments, a action desinhibitrice, qui en comportent
FR2510997A1 (fr) * 1981-08-10 1983-02-11 Sanofi Sa Nouveaux derives de la methyl-4 phenyl-6 pyridazine, procede pour leur preparation et medicaments actifs sur le systeme nerveux central en contenant
FR2539739B1 (fr) * 1983-01-24 1985-11-22 Sanofi Sa Nouveaux derives de la naphtyl pyridazine actifs sur le systeme nerveux central, procede de preparation de ces derives et medicaments en contenant

Also Published As

Publication number Publication date
DK162218C (da) 1992-03-02
EP0116494A1 (fr) 1984-08-22
PT77994B (fr) 1986-04-10
SU1274623A3 (ru) 1986-11-30
PL143994B1 (en) 1988-04-30
IE840148L (en) 1984-07-28
ES8500253A1 (es) 1984-10-01
AU566352B2 (en) 1987-10-15
KR840007587A (ko) 1984-12-08
PT77994A (fr) 1984-02-01
US4565814A (en) 1986-01-21
US4631280A (en) 1986-12-23
DK25984D0 (da) 1984-01-20
PL245932A1 (en) 1985-05-21
DK162219C (da) 1992-03-02
DK159969C (da) 1991-05-27
DK159969B (da) 1991-01-07
AU2372884A (en) 1984-08-02
YU14184A (en) 1986-10-31
IE56750B1 (en) 1991-12-04
GR81682B (en:Method) 1984-12-12
DK162219B (da) 1991-09-30
IL70755A0 (en) 1984-04-30
CS61484A2 (en) 1990-09-12
FI840349L (fi) 1984-07-29
DK621689A (da) 1989-12-08
ES529108A0 (es) 1984-10-01
PH21476A (en) 1987-10-28
CS274405B2 (en) 1991-04-11
SG9389G (en) 1989-07-07
DK621689D0 (da) 1989-12-08
OA07645A (fr) 1985-05-23
EP0116494B1 (fr) 1988-01-27
FI840349A0 (fi) 1984-01-27
KR910000639B1 (ko) 1991-01-31
DK621589A (da) 1989-12-08
CA1218655A (en) 1987-03-03
NO840329L (no) 1984-07-30
IL70755A (en) 1987-03-31
NZ206957A (en) 1987-06-30
FI77453B (fi) 1988-11-30
DE3469026D1 (en) 1988-03-03
DK621589D0 (da) 1989-12-08
HU192975B (en) 1987-08-28
DK162218B (da) 1991-09-30
DK25984A (da) 1984-07-29
FI77453C (fi) 1989-03-10
DD215542A5 (de) 1984-11-14

Similar Documents

Publication Publication Date Title
MA20019A1 (fr) Procede pour l'obtention de derives de la pyridazine ayant une action psychotrope.
RO91184A (ro) Procedeu pentru prepararea unor derivati de 2,2'-iminobesetanol
PT77993B (fr) Procede pour l'obtention de derives de la pyridazine amino-substitues en position 3 actifs sur le systeme nerveux central
RO84802A (ro) Procedeu pentru obtinerea unor(1-aril-ciclobutil)alchilamine
RO93871A (ro) Procedeu de obtinere a unor derivati de propargiloxiacetonitril substituiti
MA20180A1 (fr) Procede pour l'obtention de derives de la benzamidine a activite antimicrobienne
FR2664279B1 (fr) Procede d'obtention de kappa carraghenanes.
FR2592660B1 (fr) Procede d'obtention de mout.
RO83468A (ro) Procedeu de obtinere a derivatilor de 5,6,7,7a-4h-tieno/3,2-c/-piridin-2-onei
FR2662168B1 (fr) Procede pour l'obtention de polyamides-imides semi-ordonnes.
FR2549042B1 (fr) Procede pour la preparation de la 3,11-dimethyl-2-nonacosanone
FR2554111B1 (fr) Procede d'obtention en continu de copolymeres
FR2678185B1 (fr) Lingotiere perfectionnee et procede pour l'obtention de lingots gerbables notamment en zinc.
RO90402A2 (ro) Procedeu pentru obtinerea hidrazodicarboxamidei
ES510626A0 (es) "un metodo de producir derivados de cefalosporina".
FR2662183B1 (fr) Procede electrolytique pour la preparation de derives cyclopropaniques.
FR2549830B1 (fr) Nouveau procede d'obtention de quinoleines substituees
RO83009A2 (ro) Procedeu pentru obtinerea magnetitei
RO88701A2 (ro) Procedeu de obtinere alfa-l-aspartil-l-fenilalaninatului de metil
MA19808A1 (fr) Procede d'obtention de dialkylphosphonates .
FR2678949B1 (fr) Procede d'obtention d'un complexe proteique d'action stabilisatrice de la degenerescence.
RO81615A (ro) Procedeu de obtinere a unor derivati de nitrobenzonitril
RO85601A2 (ro) Procedeu de obtinere a n-pentanului
RO89759A2 (ro) Procedeu de obtinere a adenozintrifosfatului de sodiu
RO86120A (ro) Procedeu pentru obtinerea unui condensat ureoformaldehidic